Hi members,
I am currently preparing an overview presentation for my science colleagues (unfamiliar with NGS) on the next- and now-gen sequencing technologies. Obviously, this forum is a great place to fill the gaps in my knowledge - but I was left wondering about one question:
Why is llumina the dominant platform?
As a non-instrument owner, I could think about things like ease-of-use, instument price, popularity, bioinformatics quality, customer support, first on the market, reliability etc.
Don't get me wrong, I don't want to buy an instrument, and I know a little about the advantages of the platforms - but that taken together doesn't help me in understanding why Illumina is the market leader.
So I want to know from you:
What is your notion of the success of Illumina? (Facts welcome )
I am currently preparing an overview presentation for my science colleagues (unfamiliar with NGS) on the next- and now-gen sequencing technologies. Obviously, this forum is a great place to fill the gaps in my knowledge - but I was left wondering about one question:
Why is llumina the dominant platform?
As a non-instrument owner, I could think about things like ease-of-use, instument price, popularity, bioinformatics quality, customer support, first on the market, reliability etc.
Don't get me wrong, I don't want to buy an instrument, and I know a little about the advantages of the platforms - but that taken together doesn't help me in understanding why Illumina is the market leader.
So I want to know from you:
What is your notion of the success of Illumina? (Facts welcome )
Comment